{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:45:33Z","timestamp":1761129933188,"version":"3.41.2"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>The immunological response of patients with cryptococcal meningitis (CM), particularly those not known to be immunocompromised, has generated an increased interest recently. Although CM is an infection with significant rates of morbidity and mortality, its sequelae may also include a post-infectious inflammatory response syndrome (PIIRS) in patients who have already achieved microbiological control. PIIRS can cause substantial immune-mediated damage to the central nervous system resulting in long-term neurological disability or even death. Steroids have been used successfully in the management of PIIRS in adults. In this report, we present the case of a previously healthy adolescent male with <jats:italic>Cryptococcus gattii<\/jats:italic> meningitis who experienced neurological deterioration due to PIIRS after the initiation of antifungal therapy. Immunological workup did not demonstrate any frank underlying immunodeficiencies, and genetic primary immunodeficiency screening was unremarkable. He was treated with steroids and recovered clinically; however, intermittent inflammatory episodes needed to be managed through several flares of symptoms. In the setting of the current literature, we discuss the management and monitoring of PIIRS in a pediatric patient, along with considerations of targeted future therapies.<\/jats:p>","DOI":"10.3389\/fped.2021.703895","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T10:35:10Z","timestamp":1629887710000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case Report: Paradoxical Inflammatory Response Syndrome in a Previously Healthy, HIV-Negative, Pediatric Patient With Cryptococcus gatii Meningitis"],"prefix":"10.3389","volume":"9","author":[{"given":"Jessica H.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritu","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria R.","family":"Dimitriades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e56269","DOI":"10.1371\/journal.pone.0056269","article-title":"Epidemiology of cryptococcal meningitis in the US: 1997-2009","volume":"8","author":"Pyrgos","year":"2013","journal-title":"PLoS ONE"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1097\/INF.0b013e3181fbc83d","article-title":"Epidemiology of cryptococcal infection in hospitalized children","volume":"29","author":"Joshi","year":"2010","journal-title":"Pediatric Infect Dis J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1186\/s12879-016-1964-6","article-title":"Characteristics and outcomes of cryptococcal meningitis in HIV seronegative children in Beijing, China, 2002-2013","volume":"16","author":"Guo","year":"2016","journal-title":"BMC Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar1917","article-title":"Interleukin-6 and chronic inflammation","volume":"8","author":"Gabay","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fimmu.2019.00066","article-title":"Resistance and tolerance to Cryptococcal infection: an intricate balance that controls the development of disease","volume":"10","author":"Shourian","year":"2019","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1004884","DOI":"10.1371\/journal.ppat.1004884","article-title":"Paradoxical immune responses in non-HIV cryptococcal meningitis","volume":"11","author":"Panackal","year":"2015","journal-title":"PLoS Pathog"},{"key":"B8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/jnnp-2017-315830","article-title":"Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis","volume":"89","author":"Mehta","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/cid\/ciw739","article-title":"Spinal arachnoiditis as a complication of cryptococcal meningoencephalitis in non-HIV previously healthy adults","volume":"64","author":"Panackal","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"9184","DOI":"10.1038\/s41598-017-09694-0","article-title":"Choroid plexitis and ependymitis by magnetic resonance imaging are biomarkers of neuronal damage and inflammation in HIV-negative cryptococcal meningoencephalitis","volume":"7","author":"Hammoud","year":"2017","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s10096-017-3142-1","article-title":"Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter Infectious Diseases International Research Initiative (ID-IRI) cryptococcal meningitis study","volume":"37","author":"Hakyemez","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cyto.2015.10.001","article-title":"CSF cytokines\/chemokines as biomarkers in neuroinflammatory CNS disorders: a systematic review","volume":"77","author":"Kothur","year":"2016","journal-title":"Cytokine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"18442","DOI":"10.1038\/s41598-019-54876-7","article-title":"HIV-Negative cryptococcal meningoencephalitis results in a persistent frontal-subcortical syndrome","volume":"9","author":"Traino","year":"2019","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1901.","article-title":"Outcomes in previously healthy cryptococcal meningoencephalitis patients treated with pulse - taper corticosteroids for post-infectious inflammatory syndrome","author":"Anjum","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","article-title":"Cryptococcosis","volume":"30","author":"Maziarz","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","article-title":"Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis","volume":"190","author":"Rosen","year":"2013","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"mBio"},{"key":"B18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1574-695X.1996.tb00225.x","article-title":"Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans","volume":"13","author":"Kawakami","year":"1996","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s40265-017-0829-7","article-title":"Tocilizumab: a review in rheumatoid arthritis","volume":"77","author":"Scott","year":"2017","journal-title":"Drugs"},{"key":"B20","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","article-title":"Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study","volume":"13","author":"Lee","year":"2016","journal-title":"Neurotherapeutics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pediatrneurol.2018.07.016","article-title":"Tocilizumab in refractory autoimmune encephalitis: a series of pediatric cases","volume":"86","author":"Randell","year":"2018","journal-title":"Pediatr Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","article-title":"Novel treatment strategies in rheumatoid arthritis","volume":"389","author":"Burmester","year":"2017","journal-title":"Lancet"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.703895\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T10:35:12Z","timestamp":1629887712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.703895\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":22,"alternative-id":["10.3389\/fped.2021.703895"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.703895","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2021,8,25]]},"article-number":"703895"}}